SIRT1 and diabetic kidney disease: In addition, isoliquiritigenin also has a good therapeutic effect on kidney injury in diabetic nephropathy and treats renal fibrosis by regulating oxidative stress and inflammation mediated by the SIRT1 pathway [35].